NuvaRing
These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. NuvaRing (etonogestrel/ethinyl estradiol vaginal ring)Initial U.S. Approval: 2001
Approved
Approval ID
a280f164-2833-4f37-96e3-a857c91f77f2
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 5, 2016
Manufacturers
FDA
Central Texas Community Health Centers
DUNS: 079674019
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
etonogestrel and ethinyl estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code76413-131
Application NumberNDA021187
Product Classification
M
Marketing Category
C73594
G
Generic Name
etonogestrel and ethinyl estradiol
Product Specifications
Route of AdministrationVAGINAL
Effective DateFebruary 5, 2016
FDA Product Classification
INGREDIENTS (5)
etonogestrelActive
Quantity: 0.12 mg in 1 d
Code: 304GTH6RNH
Classification: ACTIB
ethinyl estradiolActive
Quantity: 0.015 mg in 1 d
Code: 423D2T571U
Classification: ACTIB
ethylene-vinyl acetate copolymer (28% vinyl acetate)Inactive
Code: 8ILA5X28VS
Classification: IACT
ethylene-vinyl acetate copolymer (9% vinylacetate)Inactive
Code: 4OKC630HS6
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT